Hyperion Therapeutics To Present At The Leerink Swann Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Leerink Swann Global Healthcare Conference on Thursday, February 14 at 3:00 p.m. ET (12:00 p.m. PT).

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company overview. To access the live webcast and subsequent archived recording, please visit Hyperion's website at http://investors.hyperiontx.com/events.cfm.

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases and hepatology. For more information, please visit www.hyperiontx.com
CONTACT: Shari Annes, Investor Relations         (650) 888-0902         sannes@annesassociates.com                  Kristie Kuhl, Media Relations         (203) 556-7417         kkuhl@makovsky.com

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX